DDInter948 DDInter699
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
Etodolac is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. Its therapeutic effects are due to its ability to inhibit prostaglandin synthesis. It is indicated for relief of signs and symptoms of rheumatoid arthritis and osteoarthritis.
Etodolac {u} (Compound) binds {v} (Gene) CYP2C9
Etodolac {u} (Compound) upregulates {v} (Gene) SERPINA3
Etodolac {u} (Compound) palliates {v} (Disease) osteoarthritis
Etodolac {u} (Compound) is included by {v} (Pharmacologic Class) Nonsteroidal Anti-inflammatory Compounds
Etodolac {u} (Compound) downregulates {v} (Gene) RAI14
Etodolac {u} (Compound) causes {v} (Side Effect) Rhinitis
Etodolac {u} may cause a minor interaction that can limit clinical effects when taken with {v} Linaclotide
Etodolac {u} may cause a minor interaction that can limit clinical effects when taken with {v} Nizatidine
Etodolac {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Anistreplase
Etodolac {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Sodium sulfate
Etodolac (Compound) binds CYP2C9 (Gene)
Etodolac (Compound) upregulates SERPINA3 (Gene)
Etodolac (Compound) palliates osteoarthritis (Disease)
Etodolac (Compound) is included by Nonsteroidal Anti-inflammatory Compounds (Pharmacologic Class)
Etodolac (Compound) downregulates RAI14 (Gene)
Etodolac (Compound) causes Rhinitis (Side Effect)
Etodolac may cause a minor interaction that can limit clinical effects when taken with Linaclotide
Etodolac may cause a minor interaction that can limit clinical effects when taken with Nizatidine
Etodolac may cause a moderate interaction that could exacerbate diseases when taken with Anistreplase
Etodolac may cause a moderate interaction that could exacerbate diseases when taken with Sodium sulfate